| CTO lesion group (88) | Non-CTO lesion group (44) | p value |
Follow up at 1 years |
|
|
|
MACE | 4 (4.5%) | 7 (15.9%) | 0.026 |
Target vessel revascularization | 0 (0 %) | 1 (2.3 %) | 0.156 |
Non-target vessel revascularization | 7 (7.9 %) | 9 (20.4%) | 0.038 |
CABG | 0 (0 %) | 1 (2.3 %) | 0.156 |
All cause death | 0 (0 %) | 1 (2.3 %) | 0.156 |
Follow up at 2 years |
|
|
|
MACE | 7 (7.9 %) | 10 (22.7 %) | 0.017 |
Target vessel revascularization | 3 (6.8 %) | 2 (4.5 %) | 0.474 |
Non-target vessel revascularization | 10 (11.3 %) | 12 (27.3 %) | 0.021 |
CABG | 1 (1.13 %) | 2 (4.54 %) | 0.215 |
All cause death | 2 (2.3 %) | 3 (6.8 %) | 0.197 |